Scienze Della Vita 2025: Italy’s Untapped Potential

This report examines the future of Italy’s healthcare and life sciences sectors, spotlighting both ongoing challenges and growing opportunities. While the country’s universal healthcare system delivers strong outcomes, it continues to struggle with underinvestment, workforce shortages, and regional disparities. At the same time, Italy’s life sciences industry is gaining momentum, with over 800 biotech firms generating nearly $15 billion in revenue. As Milan emerges as a major innovation hub, Scienze Della Vita 2025 outlines a roadmap to unlock the country’s untapped potential and position Italy as a European leader in life sciences.

Executive Forecast

July 10, 2025